Evaluating the Role of Nitric Oxide Synthase (NOS) Expression in Oral Submucosal and Mucosal Lesions: A Molecular Pathology Schematic Approach
DOI:
https://doi.org/10.68041/johdt.v1i1/04Keywords:
Biomarkers, carcinoma, squamous cell, leukoplakia, mouth mucosa, nitric oxideAbstract
Nitric oxide (NO) signaling is involved in inflammatory processes, epithelial homeostasis, vascular function, and tissue remodeling, making it possible that expression of nitric oxide synthase (NOS) could be involved in oral mucosal and submucosal lesions. The aim of this narrative review is to discuss the reported expression patterns of NOS isoforms, their underlying molecular mechanisms, and the possible diagnostic and prognostic use. Oral leukoplakia and oral squamous cell carcinoma (OSCC) studies suggest that in certain cohorts there is increased expression of inducible NOS (NOS2/iNOS); however, these studies are limited by small sample size, methodological heterogeneity, and predominantly cross-sectional study design. There is still inconclusive evidence for oral submucous fibrosis and other potentially malignant disorders having consistent associations or independent prognosis. The distribution of NOS protein can be characterized by immunohistochemistry, which should be complemented by molecular and functional assays. Importantly, expression of NOS does not necessarily denote enzymatic activity or bioavailability of NO. The use of standardized methods and the assessment of isoforms, spatial analysis, and prospective multicenter validation are required before the establishment of NOS-derived biomarkers in routine oral pathology.
References
1. Jayasinghe RD, Siriwardena BSMS. Clinical aspects of oral cancer and potentially malignant disorders with special relevance to South Asia. Ann Maxillofac Surg. 2025;14(2):128–136. https://doi.org/10.4103/ams.ams_184_24 DOI: https://doi.org/10.4103/ams.ams_184_24
2. Meka NJ, Ugrappa S, Velpula N, Kumar S, Maloth KN, Kodangal S, et al. Quantitative immunoexpression of EGFR in oral potentially malignant disorders: oral leukoplakia and oral submucous fibrosis. J Dent Res Dent Clin Dent Prospects. 2015;9(3):166–174. https://doi.org/10.15171/joddd.2015.031 DOI: https://doi.org/10.15171/joddd.2015.031
3. Chachlaki K, Prevot V. Nitric oxide signalling in the brain and its control of bodily functions. Br J Pharmacol. 2020;177(24):5437–5458. https://doi.org/10.1111/bph.14800 DOI: https://doi.org/10.1111/bph.14800
4. Miranda KM, Ridnour LA, Cheng RYS, Wink DA, Thomas DD. The chemical biology of NO that regulates oncogenic signaling and metabolism: NOS2 and its role in inflammatory disease. Crit Rev Oncog. 2023;28(1):27–45. https://doi.org/10.1615/CritRevOncog.2023047302 DOI: https://doi.org/10.1615/CritRevOncog.2023047302
5. Singh DN, Srivastava KC, Potsangbam AD, Shrivastava D, Nandini DB, Singh WT, et al. A case-control study comparing and correlating iNOS expression among various clinicopathological variants of oral leukoplakia and oral squamous cell carcinoma: an immunohistochemistry study. J Pharm Bioallied Sci. 2020;12(Suppl 1):S324–S331. https://doi.org/10.4103/jpbs.JPBS_96_20 DOI: https://doi.org/10.4103/jpbs.JPBS_96_20
6. Kimble R, Shannon OM. Can beetroot (Beta vulgaris) support brain health? A perspective review on Alzheimer’s disease. Nutrients. 2025;17(23):3790. https://doi.org/10.3390/nu17233790 DOI: https://doi.org/10.3390/nu17233790
7. Sardaro N, Della Vella F, Incalza MA, Di Stasio D, Lucchese A, Contaldo M, et al. Oxidative stress and oral mucosal diseases: an overview. In Vivo. 2019;33(2):289–296. https://doi.org/10.21873/invivo.11474 DOI: https://doi.org/10.21873/invivo.11474
8. Su Y. Regulation of endothelial nitric oxide synthase activity by protein-protein interaction. Curr Pharm Des. 2014;20(22):3514–3520. https://doi.org/10.2174/13816128113196660752 DOI: https://doi.org/10.2174/13816128113196660752
9. Tran N, Garcia T, Aniqa M, Ali S, Ally A, Nauli SM. Endothelial nitric oxide synthase (eNOS) and the cardiovascular system: in physiology and in disease states. Am J Biomed Sci Res. 2022;15(2):153–177. https://doi.org/10.34297/AJBSR.2022.15.002087 DOI: https://doi.org/10.34297/AJBSR.2022.15.002087
10. Ambe K, Watanabe H, Takahashi S, Nakagawa T, Sasaki J. Production and physiological role of NO in the oral cavity. Jpn Dent Sci Rev. 2016;52(1):14–21. https://doi.org/10.1016/j.jdsr.2015.08.001 DOI: https://doi.org/10.1016/j.jdsr.2015.08.001
11. Piacenza L, Zeida A, Trujillo M, Radi R. The superoxide radical switch in the biology of nitric oxide and peroxynitrite. Physiol Rev. 2022;102(4):1881–1906. https://doi.org/10.1152/physrev.00005.2022 DOI: https://doi.org/10.1152/physrev.00005.2022
12. Andrabi SM, Sharma NS, Karan A, Shahriar SMS, Cordon B, Ma B, et al. Nitric oxide: physiological functions, delivery, and biomedical applications. Adv Sci (Weinh). 2023;10(30):2303259. https://doi.org/10.1002/advs.202303259 DOI: https://doi.org/10.1002/advs.202303259
13. Lee DW, Jang SH, Kim TK, Kim H, Byeon JY, Choi H. Comparative study of inflammatory and fibrotic reactions induced by silicone implants with different hardness. Plast Reconstr Surg. 2025;156(4):567–577. https://doi.org/10.1097/PRS.0000000000012055 DOI: https://doi.org/10.1097/PRS.0000000000012055
14. Saez A, Herrero-Fernandez B, Gomez-Bris R, Sánchez-Martinez H, Gonzalez-Granado JM. Pathophysiology of inflammatory bowel disease: innate immune system. Int J Mol Sci. 2023;24(2):1526. https://doi.org/10.3390/ijms24021526 DOI: https://doi.org/10.3390/ijms24021526
15. Chhabra AK, Sune R, Reche A. Oral submucous fibrosis: a review of the current concepts in management. Cureus. 2023;15(10):e47259. https://doi.org/10.7759/cureus.47259 DOI: https://doi.org/10.7759/cureus.47259
16. Pimenta-Barros LA, Ramos-García P, González-Moles MÁ, Aguirre-Urizar JM, Warnakulasuriya S. Malignant transformation of oral leukoplakia: systematic review and comprehensive meta-analysis. Oral Dis. 2025;31(1):69–80. https://doi.org/10.1111/odi.15140 DOI: https://doi.org/10.1111/odi.15140
17. Pentenero M, Meleti M, Vescovi P, Gandolfo S. Oral proliferative verrucous leucoplakia: are there particular features for such an ambiguous entity? A systematic review. Br J Dermatol. 2014;170(5):1039–1047. https://doi.org/10.1111/bjd.12853 DOI: https://doi.org/10.1111/bjd.12853
18. Tjingson N, Rizal MI, Sandra F. The tumor microenvironment of oral squamous cell carcinoma: cellular components and their therapeutic targets. Mol Cell Biomed Sci. 2026;10(2):82–92. https://doi.org/10.21705/mcbs.v10i2.784 DOI: https://doi.org/10.21705/mcbs.v10i2.784
19. Sangle V, Chaware S, Kulkarni MA, Ingle Y, Singh P, Pooja V. Elevated tissue nitric oxide in oral squamous cell carcinoma. J Oral Maxillofac Pathol. 2018;22(1):35. https://doi.org/10.4103/jomfp.JOMFP_27_16 DOI: https://doi.org/10.4103/jomfp.JOMFP_27_16
20. Bouaoud J, Foy JP, Tortereau A, Michon L, Lavergne V, Gadot N, et al. Early changes in the immune microenvironment of oral potentially malignant disorders reveal an unexpected association of M2 macrophages with oral cancer free survival. Oncoimmunology. 2021;10(1):1944554. https://doi.org/10.1080/2162402X.2021.1944554 DOI: https://doi.org/10.1080/2162402X.2021.1944554
21. Kavitha L, Ranganathan K, Shyam S, Fathima JHS, Umesh W, Warnakulasuriya S. Immunohistochemical biomarkers in oral submucous fibrosis: a scoping review. J Oral Pathol Med. 2022;51(6):594–602. https://doi.org/10.1111/jop.13280 DOI: https://doi.org/10.1111/jop.13280
22. Lundberg JO, Weitzberg E. Nitric oxide signaling in health and disease. Cell. 2022;185(16):2853–2878. https://doi.org/10.1016/j.cell.2022.06.010 DOI: https://doi.org/10.1016/j.cell.2022.06.010
23. Goldsmith JD, Troxell ML, Roy-Chowdhuri S, Colasacco CF, Edgerton ME, Fitzgibbons PL, et al. Principles of analytic validation of immunohistochemical assays: guideline update. Arch Pathol Lab Med. 2024;148(6):e111–e153. https://doi.org/10.5858/arpa.2023-0483-CP DOI: https://doi.org/10.5858/arpa.2023-0483-CP
24. Martinez-Castillo M, Hernández-Ramírez VI, Talamás-Rohana P, Rubio-Gutiérrez IC, Shibayama M, Serrano-Luna J. In situ cytokine expression, nitric oxide and reactive oxygen species production during primary amoebic meningoencephalitis development. Int J Mol Sci. 2026;27(19):8693. https://doi.org/10.3390/ijms27198693 DOI: https://doi.org/10.3390/ijms27198693
25. Krzystek-Korpacka M, Korpacki A, Wąsowicz A, Neubauer K. Regulation of inducible nitric oxide synthase (NOS2) expression in healthy and inflamed bowel: a narrative review. Int J Mol Sci. 2026;27(18):8359. https://doi.org/10.3390/ijms27188359 DOI: https://doi.org/10.3390/ijms27188359
26. Islam BU, Habib S, Ahmad P, Allarakha S, Moinuddin, Ali A. Pathophysiological role of peroxynitrite induced DNA damage in human diseases: a special focus on poly(ADP-ribose) polymerase (PARP). Indian J Clin Biochem. 2015;30(4):368–385. https://doi.org/10.1007/s12291-014-0475-8 DOI: https://doi.org/10.1007/s12291-014-0475-8
27. Mikhailenko VM, Muzalov II. Exogenous nitric oxide potentiate DNA damage and alter DNA repair in cells exposed to ionising radiation. Exp Oncol. 2013;35(4):318–324. https://pubmed.ncbi.nlm.nih.gov/24382445/
28. Vieira HLA, Kroemer G. Mitochondria as targets of apoptosis regulation by nitric oxide. IUBMB Life. 2003;55(10–11):613–616. https://doi.org/10.1080/15216540310001639652 DOI: https://doi.org/10.1080/15216540310001639652
29. Khan FH, Dervan E, Bhattacharyya DD, McAuliffe JD, Miranda KM, Glynn SA. The role of nitric oxide in cancer: master regulator or NOt? Int J Mol Sci. 2020;21(24):9393. https://doi.org/10.3390/ijms21249393 DOI: https://doi.org/10.3390/ijms21249393
30. Nowak-Sliwinska P, Alitalo K, Allen E, Anisimov A, Aplin AC, Auerbach R, et al. Consensus guidelines for the use and interpretation of angiogenesis assays. Angiogenesis. 2018;21(3):425–532. https://doi.org/10.1007/s10456-018-9613-x DOI: https://doi.org/10.1007/s10456-018-9613-x
31. Kamran S, Reza N, Berahim Z, Rahman SU, Abdullah JY. Fibrotic–angiogenic signaling networks in oral submucous fibrosis: pathobiology and therapeutic targeting. Int J Mol Sci. 2026;27(16):7204. https://doi.org/10.3390/ijms27167204 DOI: https://doi.org/10.3390/ijms27167204
32. Schuster R, Younesi F, Ezzo M, Hinz B. The role of myofibroblasts in physiological and pathological tissue repair. Cold Spring Harb Perspect Biol. 2023;15(1):a041231. https://doi.org/10.1101/cshperspect.a041231 DOI: https://doi.org/10.1101/cshperspect.a041231
33. Najafi T, Ghaffari Novin M, Pakravesh J, Foghi K, Fadayi F, Rahimi G. Immunohistochemical localization of endothelial nitric oxide synthase in endometrial tissue of women with unexplained infertility. Iran J Reprod Med. 2012;10(2):121–126. https://pubmed.ncbi.nlm.nih.gov/25242984/
34. Shnayder NA, Petrova MM, Moskaleva PV, Shesternya PA, Pozhilenkova EA, Nasyrova RF. The role of single-nucleotide variants of NOS1, NOS2, and NOS3 genes in the comorbidity of arterial hypertension and tension-type headache. Molecules. 2021;26(6):1556. https://doi.org/10.3390/molecules26061556 DOI: https://doi.org/10.3390/molecules26061556
35. Bong D, Sohn J, Lee SJV. Brief guide to RT-qPCR. Mol Cells. 2024;47(12):100141. https://doi.org/10.1016/j.mocell.2024.100141 DOI: https://doi.org/10.1016/j.mocell.2024.100141
36. Csonka C, Páli T, Bencsik P, Görbe A, Ferdinandy P, Csont T. Measurement of NO in biological samples. Br J Pharmacol. 2015;172(6):1620–1632. https://doi.org/10.1111/bph.12832 DOI: https://doi.org/10.1111/bph.12832
37. Roy-Chowdhuri S. The updated College of American Pathologists principles of analytic validation of immunohistochemical assays: a step forward for cytopathology. Cancer Cytopathol. 2024;132(9):547–548. https://doi.org/10.1002/cncy.22818 DOI: https://doi.org/10.1002/cncy.22818
38. Webster JD, Solon M, Gibson-Corley KN. Validating immunohistochemistry assay specificity in investigative studies: considerations for a weight of evidence approach. Vet Pathol. 2021;58(5):829–840. https://doi.org/10.1177/0300985820960132 DOI: https://doi.org/10.1177/0300985820960132
39. Silva Servato JP, Vieira CU, de Faria PR, Cardoso SV, Loyola AM. The importance of inducible nitric oxide synthase and nitrotyrosine as prognostic markers for oral squamous cell carcinoma. J Oral Pathol Med. 2019;48(10):967–975. https://doi.org/10.1111/jop.12942 DOI: https://doi.org/10.1111/jop.12942
40. Arockiam S, Raj B, Prabha N, Dharani M. Diagnostic utility of immunofluorescence in oral lesions: a systematic review. J Oral Maxillofac Res. 2024;15(3):e2. https://doi.org/10.5037/jomr.2024.15302 DOI: https://doi.org/10.5037/jomr.2024.15302
41. Fallatah MH, Ahmad AM, Alabbas KA, Alhammad LA. An overview of histological staining techniques. J Posthumanism. 2025;5(8). https://doi.org/10.63332/joph.v5i8.3191 DOI: https://doi.org/10.63332/joph.v5i8.3191
42. Bhattarai BP, Singh AK, Singh RP, Chaulagain R, Søland TM, Hasséus B, et al. Recurrence in oral leukoplakia: a systematic review and meta-analysis. J Dent Res. 2024;103(11):1066–1075. https://doi.org/10.1177/00220345241266519 DOI: https://doi.org/10.1177/00220345241266519
43. Liu Z, Zhang Z, Zhang Y, Zhou W, Zhang X, Peng C, et al. Spatial transcriptomics reveals that metabolic characteristics define the tumor immunosuppression microenvironment via iCAF transformation in oral squamous cell carcinoma. Int J Oral Sci. 2024;16(1):9. https://doi.org/10.1038/s41368-023-00267-8 DOI: https://doi.org/10.1038/s41368-023-00267-8
44. Reimegård J, Tarbier M, Danielsson M, Schuster J, Baskaran S, Panagiotou S, et al. A combined approach for single-cell mRNA and intracellular protein expression analysis. Commun Biol. 2021;4(1):624. https://doi.org/10.1038/s42003-021-02142-w DOI: https://doi.org/10.1038/s42003-021-02142-w
Published
Issue
Section
License
Copyright (c) 2026 Ejaz Ahmed, Ayisha Yousaf, Maryum Qasim (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Oral Health and Dental Therapeutics (JOHDT) follows the Attribution Creative Commons-Non commercial (CC BY-NC 4.0) license which allows the users to copy and redistribute the material in any medium or format, remix, transform and build upon the material. The users must give credit to the source and indicate, provide a link to the license, and indicate if changes were made. However, the CC BY-NC 4.0 license restricts the use of material for commercial purposes (Further details are available at website. The Editorial Board of the JOHDT endeavors to ensure the accuracy, integrity, and quality of all published content. However, the responsibility of opinions, interpretations, and conclusions expressed in the published articles rests entirely with the authors and do not necessarily reflect the views of the Editorial Board, publisher, or affiliated institutions.
